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Cyclic Di-GMP Phosphodiesterases RmdA and RmdB Are Involved in
Regulating Colony Morphology and Development in Streptomyces
coelicolor
Travis D. Hull,a* Min-Hyung Ryu,b Matthew J. Sullivan,a* Ryan C. Johnson,a* Nikolai T. Klena,a Robert M. Geiger,c Mark Gomelsky,b
and Jennifer A. Bennetta,c
Department of Biology, Juniata College, Huntingdon, Pennsylvania, USAa; Department of Molecular Biology, University of Wyoming, Laramie, Wyoming, USAb; and
Department of Biology and Earth Science, Otterbein University, Westerville, Ohio, USAc
Cyclic dimeric GMP (c-di-GMP) regulates numerous processes in Gram-negative bacteria, yet little is known about its role in
Gram-positive bacteria. Here we characterize two c-di-GMP phosphodiesterases from the filamentous high-GC Gram-positive
actinobacterium Streptomyces coelicolor, involved in controlling colony morphology and development. A transposon mutation
in one of the two phosphodiesterase genes, SCO0928, hereby designated rmdA (regulator ofmorphology and development A),
resulted in decreased levels of spore-specific gray pigment and a delay in spore formation. The RmdA protein contains GGDEF-
EAL domains arranged in tandem and possesses c-di-GMP phosphodiesterase activity, as is evident from in vitro enzymatic as-
says using the purified protein. RmdA contains a PAS9 domain and is a hemoprotein. Inactivation of another GGDEF-EAL-en-
coding gene, SCO5495, designated rmdB, resulted in a phenotype identical to that of the rmdAmutant. Purified soluble fragment
of RmdB devoid of transmembrane domains also possesses c-di-GMP phosphodiesterase activity. The rmdA rmdB double mu-
tant has a bald phenotype and is impaired in aerial mycelium formation. This suggests that RmdA and RmdB functions are addi-
tive and at least partially overlapping. The rmdA and rmdBmutations likely result in increased local pools of intracellular c-di-
GMP, because intracellular c-di-GMP levels in the single mutants did not differ significantly from those of the wild type, whereas
in the double rmdA rmdBmutant, c-di-GMP levels were 3-fold higher than those in the wild type. This study highlights the im-
portance of c-di-GMP-dependent signaling in actinomycete colony morphology and development and identifies two c-di-GMP
phosphodiesterases controlling these processes.
Cyclic diguanosine monophosphate (c-di-GMP) is a ubiqui-tous second messenger in bacteria. Since its identification by
Moshe Benziman and colleagues and characterization as an allo-
steric activator of cellulose synthase in Gluconacetobacter xylinus
(formerlyAcetobacter xylinum) (47), c-di-GMPhas been shown to
coordinate numerous cellular activities, including biofilm forma-
tion,motility, cell cycle progression, and virulence. c-di-GMP reg-
ulates these processes by affecting the synthesis and activities of
flagella, pili, adhesins, exopolysaccharides, and extracellularDNA,
as well as virulence factors. It plays important roles in the cellular
transition from amotile to surface-attached lifestyle, from forma-
tion to dissolution of biofilms, and, in pathogens, from acute to
chronic infections and from one host to another (reviewed in
references 26, 45, 52, 55, and 65).
Intracellular c-di-GMP levels are inversely regulated by
diguanylate cyclases (DGCs) involved in c-di-GMP synthesis
and by c-di-GMP-specific phosphodiesterases (PDEs) involved
in c-di-GMP degradation (46, 47). A conserved and widely
spread GGDEF domain is responsible for the DGC activity. c-di-
GMP formation is catalyzed by a homodimer formed from two
GGDEF domains, each of which binds the substrate, GTP (11, 43,
51). The c-di-GMP-specific PDE activity is encoded by the EAL
(11, 14, 53, 56) or HD-GYP (23, 34, 49) protein domains. A large
number of c-di-GMP-metabolizing enzymes contain both GGDEF
andEALdomains arranged in tandem (54).Most of these proteins
possess only one enzymatic activity, eitherDGCor PDE. It is often
possible to predict the enzymatic activity of the GGDEF-EAL pro-
teins based on conservation of the amino acids essential for catal-
ysis. However, some enzymes are bifunctional, and their prevail-
ing activity depends on the input signal (20, 32, 57).
Changes in c-di-GMP levels affect activities of diverse c-di-
GMP receptors (effectors). Among protein-based c-di-GMP
receptors are enzymes, transcription factors, and proteins con-
trolling downstream output activities via protein-protein in-
teractions. c-di-GMP also controls gene expression via two spe-
cific classes of riboswitches (reviewed in reference 38).
At present, our knowledge of c-di-GMP signaling pathways is
limited almost exclusively to the Gram-negative bacteria (proteo-
bacteria and spirochetes). The c-di-GMP signaling pathways are
present in many Gram-positive bacteria (9), but functional stud-
ies have been done only in mycobacteria, where c-di-GMP signal-
ing appears to play a relatively limited role and is involved in
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long-term survival (32). Recent reports uncovered the involve-
ment of c-di-GMP in the development of the Gram-positive acti-
nomycete Streptomyces coelicolor (17, 59).
S. coelicolor is a nonmotile, nonpathogenic soil bacterium
characterized by a complex cycle of morphological differentiation
and therefore traditionally utilized as a model of bacterial devel-
opment. The genus Streptomyces has significant pharmacological
importance because more than two-thirds of the antibiotics cur-
rently in use are produced by its representatives. The S. coelicolor
life cycle begins when a free spore germinates to produce long,
branching vegetative filaments that grow into and on the substrate
surface. These vegetative filaments rarely divide, yielding a net-
work of multinucleated hyphae. Colony maturation leads to the
development of aerial hyphae that are erected above the colony
surface. These aerial hyphae undergo a sporulation-specific cell
division process, resulting in an aerial mycelium comprised of
uninucleoid prespores that metamorphose into gray-pigmented
mature spores (13, 22).
Here we searched for developmental mutants of S. coelicolor
following transposon mutagenesis. One mutant, resulting from
transposon insertion in the gene designated rmdA (regulator of
morphology and development A), produced a decreased amount
of gray spore pigment relative to that produced by the wild-type
strain, was delayed in sporulation, and had abnormal colonymor-
phology. The rmdA gene was found to encode a GGDEF-EAL
protein. Following genetic and biochemical analysis, we eluci-
dated that RmdA functions as a c-di-GMP PDE. Bioinformatics
analysis uncovered a potential second GGDEF-EAL PDE in S.
coelicolor. We have shown here that this protein, designated
RmdB, also acts as a c-di-GMPPDE and that the rmdBmutant has
a phenotype similar to that of the rmdAmutant. The rmdA rmdB
double mutant is completely blocked in aerial mycelium forma-
tion, which suggests that RmdA and RmdB are critical, partially
redundant, signaling enzymes regulating c-di-GMP-dependent
development in S. coelicolor.
MATERIALS AND METHODS
Bacterial strains, plasmids, and media. Strains used in this work are
listed in Table 1. The prototrophic SCP1 SCP2 strain MT1110 of S.
coelicolor A3(2) was used as the wild type (6, 30). Liquid cultures were
grown in baffled flasks containing YEME medium with 10.3% sucrose at
30°C (30). The agar media R2YE and mannitol soya flour (MS) were
prepared as described previously (30). For S. coelicolor, neomycin, apra-
mycin, and kanamycin were used at final concentrations of 10 g/ml, 25
g/ml, and 160 g/ml, respectively.
Escherichia coli SUREwas utilized for the preparation of cosmidDNA.
The damdcmmutant strains ET12567 and ER2-1were used to circumvent
the methyl-specific restriction system of S. coelicolor for propagation of
cosmid or plasmid DNA (35). E. coli strains were grown at 37°C in Luria-
Bertani medium containing, where necessary, ampicillin (100 g/ml),
apramycin (100 g/ml), and/or kanamycin (50 g/ml).
Bioinformatics analysis. The S. coelicolor genome database was
searched for annotated gene and protein sequences. Protein sequences
were analyzed by the SMART (33) and Pfam (21) domain databases.
BLAST software was employed to identify homologous proteins in other
bacteria. Multiple sequence alignments were constructed using ClustalW
on the BiologyWorkbench 3.2 software platform (http://workbench.sdsc
.edu/).
Colony morphology and sporulation analysis. Ten colonies of con-
firmed S. coelicolor mutants grown on MS agar plates for 5 days at 30°C
were observed using a low-power photomicroscope (Meiji). Represen-
tative colonies were photographed with a color digital camera (model
CFW01312C) from the Scion Corporation. S. coelicolor spore chains
were observed under phase-contrast microscopy at total magnifica-
tion 1,000. Aerial mycelium was prepared on glass cover slides and
mounted in 50% glycerol (36). Images were captured with an Olympus
BX 40 light microscope equipped with an Olympus color digital camera
(model DP72) and cellSens software. Micrographs were processed in the
software packages ImageJ and Adobe Photoshop.
DNA preparation and manipulation. Chromosomal DNA from S.
coelicolor was isolated using the Wizard genomic DNA purification kit
(Promega). Plasmid and cosmid DNA were prepared with the QIAprep
miniprep kit (Qiagen). PCR products were prepared for DNA sequencing
using theQIAquick PCRpurification kit (Qiagen). TheDyeEX 2.0 spin kit
(Qiagen) was used for the cleanup of all DNA sequencing reactions, and
the Applied Biosystems ABI Prism 310 genetic analyzer was used to ana-
lyze sequencing reactions.
Transposon mutagenesis and insertion site analysis. The pJA77
minitransposon system is based on the Tn5 transposon containing the
aphI gene (neomycin resistance [Neor]) (4). pJA77 was isolated from E.
coli ER2-1 and transformed into wild-type S. coelicolor MT1110 (30) by
polyethylene glycol-mediated transformation (41). Following selection of
Neor colonies, we screened for Apramycin sensitivity (Apras) to ensure
transposition as opposed to plasmid integration via a single crossover.
Transformants were also plated on minimal medium, and auxotrophic
mutants were eliminated. To establish linkage between the transposon
insertion and the mutant phenotype, chromosomal DNA from the inser-
tional mutants was isolated and transformed into MT1110 protoplasts.
The Neor transformants were screened visually and by phase-contrast
microscopy (4).
To determine the transposon insertion locations, we used inverse PCR
andDNA sequencing. Chromosomal DNA from the transposon insertion
mutant was digested with Sau3AI to generate short DNA fragments that
were ligated into small circular molecules. This DNA served as the tem-
plate for an inverse PCR (invPCR) reaction utilizing the following trans-
poson-specific primers: Tn5InvF2 (5=-AGGAGACTCGGGCGCCTTCG
TABLE 1 Bacterial strains and plasmids
Strain or plasmid Relevant characteristic(s)
Reference
or source
Strains
S. coelicolor
MT1110 Prototrophic, SCP1, SCP2 30
TH1 SC00928::Tn5 This work
TH100 SCO0928::Tn5062 This work
TH101 SCO5495::Tn5062 This work
TH105 SCO0929::Tn5062 This work
TH106 SCO5495::Tn5062 SCO0928::Tn5 This work
E. coli
SURE Cloning strain Stratagene
ER2-1 dam dcmmutant to avoid Streptomycesmethyl
restriction
5
ET12567 dam dcmmutant strain with mating helper
plasmid pUZ8002
30
DH5 Host for overexpression of MBP fusions NEB
MG1655 K12 strain used in motility assays ATCC
MG1655 yhjH MG1655 yhjH::Kanr 19
Plasmids
pJA77 Mini-Tn5 delivery vector, Neor 4
pMAL-c5x MBP overexpression vector NEB
pMAL-rmdA MBP::(PAS9-GGDEF-EAL) from RmdA This work
pMAL-rmdB MBP::(GGDEF-EAL) from RmdB This work
pMAL-sco1397 MBP::SCO1397 This work
Cosmids
SCM10 SCM10.2.B08 (03071421MU); contains SCO0928 7
SCM10 SCM10.1.G03 (03021117RA); contains SCO0929 7
SC8D9 8D9.1.F04 (8BF-1 022 2007-04-18); contains
SCO5495
7
SC1A8A 1A8A.2.B09; contains SCO1397 7
c-Di-GMP Phosphodiesterases in Streptomyces Development
September 2012 Volume 194 Number 17 jb.asm.org 4643
 o
n
 O
ctober 6, 2015 by O
TTERBEIN UNIVERSITY
http://jb.asm.org/
D
ow
nloaded from
 
TCTACCAG) and Tn5InvR3 (5=-CATCATGGCAGAGGCGGAGACGC
CGTTC). The PCR products were sequenced. The nested primer
Tn5InvSeq4 (5=-GTAGGGGTTTCGGACATTCTGTG) was used to se-
quence the unknown chromosomal DNA surrounding the transposon
insertion, utilizing the known transposon sequence as a priming site. The
Basic Local Alignment Search Tool (BLAST) was used to determine the
site of transposon insertions. The Streptomyces genome database (http:
//www.sanger.ac.uk/Projects/S_coelicolor/) was used for gene and pro-
tein identification (6).
Confirmation of the transposon insertion site in SCO0928 (rmdA) was
accomplished by PCR amplification of the transposon (Tn)-containing
fragment using the following primers: SCO0928F (5=-AGGCGGCCCGT
AACGGTGCTTGAG), which anneals downstreamof the predicted trans-
poson insertion site, and Tn5Inv3R (5=-CATCATGGCAGAGGCGGAG
ACGCCGTTC), which is transposon specific. The PCR product was
sequenced. Insertions of the Tn5062 transposon in SCO0928, SCO0929,
and SCO5495 were verified in a similar manner using the following
primer pairs: SCO0928 forward (5=-TTCTCCAGGCGTTCGAAGAAG
AAG) and SCO0928/SCO0929 reverse 5=-GATGAAACCAAGCCAACCA
GGAAG); SCO0929 forward (5=-ACCATGTCGTACCCCTTGAAGAAC)
and SCO0928/SCO0929 reverse; SCO5495 forward (5=-CGCCCTGCTC
TGGTACATCCAGAC) and SCO5495 reverse (5=-TTGCCGTCGTCCTT
GAAGAAGATG).
Mutant construction. Cosmid DNA mutagenized by in vitro trans-
poson mutagenesis with a Tn5 derivative, Tn5062, was obtained from
Paul Dyson (7). ET12567 containing the helper plasmid pUZ8002 was
used as a donor in the oriT-mediated conjugal transfer of cosmid DNA
fromE. coli to S. coelicolor (42). To select for exconjugates and to eliminate
E. coli, the plates were overlaid with 25 g/ml apramycin and 20 g/ml
nalidixic acid, respectively. Apramycin-resistant (Aprar) exconjugates
were streaked on MS medium containing kanamycin to screen for kana-
mycin sensitivity (Kans). Since S. coelicolor cosmids contain bothKanr and
Ampr cassettes on the Supercos-1 backbone (44), screening forAprar Kans
colonies allowed the selection of mutant S. coelicolor colonies that had
undergone gene disruption via double-crossover recombination.
To construct the rmdA rmdB double mutant, the rmdB::Tn5062 cos-
mid was conjugated from E. coli ET12567/pUZ8002 into the rmdA mu-
tant, and Kans Aprar Neor colonies were identified and analyzed further.
For complementation, a wild-type version of one of the genes (rmdA or
rmdB) was introduced into the double mutant strain by interspecies con-
jugation, and single-crossover integrants of the cosmid were selected.
Protein overexpression and enzymatic assays. The DNA fragments
encoding the PAS9-GGDEF-EALmodule of RmdA, the GGDEF-EALmod-
ule of RmdB, and full-length SCO1397 were PCR amplified using, respec-
tively, the following primer pairs: SCO0928-F (5=-AATCATATGCATCAT
CATCATCATCACTTCGAGGGCGCCGCCATAG) and SCO0928-R (5=-A
TTGAATTCTCAGCCCGTCGCGTCC); SCO5495-F (5=-AATCATATG
CATCATCATCATCATCACCAGTTGCGCGACCCGCTC) and SCO5495-R
(5=-ATTGAATTCTCACTCGTCGCTCGCCG); and SCO1397-F (5=-AA
TCATATGCATCATCATCATCATCACATGACCGGCGGGGTCGC) and
SCO1397-R (5=-ATTGAATTCTCAGAGAGCCGTACGACGCC). The
amplified PCR fragments were digested with NdeI and EcoRI and cloned
into the same restriction sites in pMal-c5x (NEB).
Maltose-binding protein (MBP) fusions were overexpressed in E. coli
DH5 and affinity purified on amylose resin according to the specifica-
tions of the manufacturer (NEB). Briefly, the overnight cultures express-
ing MBP fusions were grown to an A600 of 0.6 in LB supplemented with
100 g/ml ampicillin at 30°C. The cultures were transferred to room
temperature, and 0.5 mM (final concentration) isopropyl 1-thio--D-ga-
lactopyranoside (IPTG) was added. Following a 15-h incubation, cells
were harvested by centrifugation and resuspended in amylose column
binding buffer (50 mM Tris-HCl, pH 8.0, 350 mMNaCl, 10 mMMgCl2,
0.5 mM EDTA, 10% glycerol). Cells were disrupted using a French pres-
sure cell, and cell debris was removed by centrifugation at 35,000 g for
45 min at 4°C. Two milliliters (bed volume) of amylose resin (NEB) pre-
equilibrated with the binding buffer was added to the soluble cell extract
derived from a 1.5-liter culture and agitated for 1 h at 4°C. The mix was
loaded onto a column, and the resin was washed with 200 ml of column
binding buffer. Fractions were eluted with 12 ml of binding buffer con-
taining 10 mM maltose. The protein was either used immediately or
stored at 80°C in 20% (vol/vol) glycerol (final concentration). Protein
concentrations were measured using a Bradford protein assay kit (Bio-
Rad) with bovine serum albumin as the protein standard. Proteins were
analyzed using SDS-PAGE.
TheDGC assays in vitrowere performed bymeasuring the rate of GTP
conversion to c-di-GMP as described by Ryjenkov et al. (51), and c-di-
GMP PDE activity assays were performed by measuring the rate of c-di-
GMP hydrolysis as described by Schmidt et al. (53). The PDE assays were
performed at room temperature in PDE assay buffer (50 mM Tris-HCl
[pH 8.5], 50 mM NaCl, 0.5 mM EDTA) containing various concentra-
tions ofMg2 and/orMn2. The initial c-di-GMP concentration was 200
M. The reactions were started by adding 1 mol purified enzyme. Ali-
quots werewithdrawn at different time points, CaCl2 was added to 10mM
to stop the reaction, and samples were boiled for 5 min. Postreaction
processing and nucleotide separation and quantification were accom-
plished by high-performance liquid chromatography (HPLC) as de-
scribed earlier (51).
Protein reconstitution with hemin and UV-vis spectroscopy. Re-
constitution of theMBP-RmdA (PAS9-GGDEF-EAL) protein fusionwith
hemin and flavins in vitro was performed essentially as described earlier
(24, 39). A reduced deoxy [Fe(II)] form of the hemoprotein was obtained
by reduction with dithionite followed by removal of the reductant using
gel filtration on a Sephadex G-25 column. The oxidized [Fe(III); met]
formwas obtained after protein incubation with an equimolar amount of
potassium ferricyanide and subsequent ferricyanide removal by gel filtra-
tion. The reduced deoxy forms with CO [Fe(II)-CO] and oxygen [Fe(II)-
O2] were obtained by gentle bubbling (for 10 min) through protein solu-
tion of CO or air, respectively. Electronic absorption UV-visible (UV-vis)
spectra were recorded using a Shimatzu UV-1601PC spectrophotometer.
Intracellular c-di-GMP extraction and measurements. Intracellular
nucleotides were extracted with 40%methanol–40% acetonitrile in 0.1 N
formic acid, following the protocol described by Bobrov et al. (8). S. coe-
licolor was grown for 70 h at 30°C on MS agar overlaid with cellophane
disks, roughly corresponding to the time of sporulation in the wild type.
Cells were scraped from the cellophane with a sterile scalpel blade, and the
wet weights were determined and matched, followed by extraction.
c-di-GMP was quantified by liquid chromatography-tandem mass
spectrometry carried out at the Mass Spectrometry Core at Michigan
State University. The levels of extracted c-di-GMP were determined
based on c-di-GMP standards. Average data from three independent
measurements are presented.
RESULTS
Identification of the rmdA gene as a regulator of morphology
and development in S. coelicolor. To identify S. coelicolor sporu-
lationmutants, we conducted in vivoTn5mutagenesis of thewild-
type strain, MT1110, using the protocol described by us earlier
(4). Colonymorphology of one of themutants, TH1 (Fig. 1B), was
aberrant compared to that of the wild-type strain. While the wild
type is characterized by a central gray region of aerial mycelium
surrounded by a ring of less-pigmented mycelium (Fig. 1A), TH1
had a white aerial myceliumwith little gray pigment. Because gray
pigment is present exclusively in spores, low pigmentation of TH1
indicated a potential sporulation defect.
To investigate the nature of this defect, we closely monitored
the sporulation process in TH1. In the wild type, mature spore
chains are comprised of individual spores that are evenly sized,
shaped, and spaced. By day three, the wild type produces long
chainswith distinct compartments containing spores separated by
Hull et al.
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fully developed septa, which can be observed by phase-contrast
microscopy. However, only very rare, short spore chains were vis-
ible in TH1 by day three (Fig. 2). On day five,most aerial filaments
in TH1 had initiated sporulation, but many spore chains con-
tained incompletely separated spores. However, by day seven, the
majority of these spore chains were fully separated (Fig. 2). These
results show that the mutation in TH1 resulted in a considerable
delay for the onset of sporulation in comparison to the wild-type
strain.
We determined that the Tn5 insertion in TH1 occurred in
codon 581 of SCO0928, hereby designated rmdA (Fig. 3A). To test
whether the sporulation defect in TH1 resulted from the Tn5 in-
sertion, we performed linkage analysis. The chromosomal DNA
from the TH1 mutant was transformed into the wild type, and
transformants expressing the Tn5-encoded Neor marker were se-
lected and assayed further. All seven analyzed transformants dis-
played a phenotype that was indistinguishable from that of the
TH1mutant (data not shown). To further verify that inactivation
of rmdA is responsible for the sporulation defect in TH1, we con-
structed a new rmdAmutant, TH100, using a cosmid that contains
a Tn5062 insertion in codon 120 of rmdA (7). In accord with our
expectations, the phenotype of the newly generated rmdA::Tn5062
mutant, TH100, displayed a sporulation phenotype indistinguish-
able from that of TH1 (data not shown).
rmdA is located downstream of SCO0929 in a putative two-
gene operon. SCO0929 encodes a conserved protein of 270 amino
acids containing a domain of unknown function, DUF574 (33).
To assess a possible role of SCO0929, we constructed a mutant
with a Tn5062 transposon mutation in SCO0929. We found that
inactivation of SCO929 did not affect sporulation (data not
shown), which suggests that rmdA is solely responsible for the
developmental delay in TH1 and TH100.
RmdA (SCO0928) functions as a c-di-GMP PDE. The rmdA
gene encodes a 714-amino-acid (aa) protein with the following
domain architecture: X-PAS9-GGDEF-EAL (Fig. 4; (21). The N-
terminal domain X of approximately 160 aa is present in signaling
proteins from numerous species in the genus Streptomyces and
other actinomycetes; however, it shows no significant similarity
with known protein domains. PAS9 belongs to a large superfamily
of PAS domains that often bind small molecules and are involved
in signal sensing and/or in protein-protein interactions (58). Se-
quence analysis of the GGDEF and EAL domains of RmdA re-
vealed that both domains contain residues essential for DGC and
PDE activities, respectively, and neither domain contains identi-
fiable deleterious mutations. Since both the GGDEF and EAL do-
mains are potentially enzymatically active, RmdAmay possess ei-
ther one activity or another or may potentially be bifunctional.
To test for enzymatic activity of RmdA, we expressed rmdA (as
an MBP fusion to the PAS9-GGDEF-EAL domain fragment) in
two E. coli test strains, MG1655 andMG1655 yhjH (19) (Table 1).
MG1655 is a highly motile strain. The inactivation of yhjH, which
encodes a dominant c-di-GMP PDE in E. coli, impairs motility in
the semisolid agar (19, 50). If RmdAhadDGC activity, it would be
expected to increase intracellular c-di-GMP levels in strain
MG1655 and decrease the diameter of the swimming zone in the
semisolid agar. However, no such decrease was detected (not
shown). If RmdAhad PDE activity, it would be expected to restore
FIG 1 Effects of inactivation of rmdA and rmdB on S. coelicolor colony morphology and aerial hyphae. (Top) Colony morphology. (A) wild type; (B) TH1
(rmdA::Tn5); (C) TH101 (rmdB::Tn5062); (D) TH106 (rmdA::Tn5 rmdB::Tn5062). Single colonies that were well separated from neighboring colonies were
selected for observation using stereomicroscopy. Images were taken on MS media after inocula of dilute spores were grown for 5 days at 30°C, yielding a few
colonies per plate. (Bottom) Aerial hyphae. (E) Reduced gray spore pigment production in rmdA and rmdB single mutants and a complete block in aerial hypha
formation in the rmdA rmdB double mutant. WT, wild type. (F) Complementation of the rmdA rmdB double mutant with the rmdA or rmdB gene. Strains were
grown at 30°C for 5 days on MS medium.
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swimming ofMG1655 yhjH in semisolid agar, and this is what was
observed (Fig. 5A).
To verify the predicted PDE function of RmdA, we overex-
pressed and purified the MBP-RmdA fusion using affinity chro-
matography. We tested enzymatic activity of the protein in vitro
(53). RmdA proved to possess c-di-GMP-specific PDE activity;
however, the relative activity in standard, Mg2-containing buf-
fers was surprisingly low. Addition of Mn2, which is known to
improve catalytic activity of c-di-GMP PDEs (3), enhanced the
PDE activity of MBP-RmdA by approximately 2-fold (Fig. 5B).
Based on the PDE activity of RmdA, we expected that the rmdA
mutation would increase intracellular levels of c-di-GMP. To test
this prediction, we extracted total nucleotides from the wild-type
andmutant TH1 grown onMS agar overlaid with cellulose mem-
branes for 70 h at 30°C and analyzed c-di-GMP content via liquid
chromatography-tandem mass spectrometry (LC-MS/MS). We
found that c-di-GMP levels did not differ significantly between
the rmdAmutant and the wild type (Fig. 6), suggesting that only a
local pool of c-di-GMPmay have been affected. Because the rmdA
mutation resulted in no gross alteration in c-di-GMP levels, we
conclude that RmdA is specifically involved in regulating S. coeli-
color development.
Bioinformatics analysis of putative S. coelicolor c-di-GMP
PDEs. To investigate whether additional c-di-GMP PDEs are in-
volved in controlling c-di-GMP-dependent development in S.
coelicolor, we performed a bioinformatics analysis of the EAL and
HD-GYP domain proteins encoded in the S. coelicolor genome. In
addition to RmdA, four other proteins, SCO1397, SCO2817,
SCO5495, and SCO5511, contain EAL domains (21) (Fig. 4), and
one, SCO5218, contains an HD-GYP domain.
The sequence of the HD-GYP domain in SCO5218 appears to
be consistent with it being enzymatically active. However, our
ability to predict activities of this class of proteins based on se-
quence analysis remains limited (34, 49). In this study, we did not
pursue experimental investigation of SCO5218.
Sequence analysis of the EAL domains in SCO1397 and
SCO5511 strongly suggested that they are incapable of hydrolyz-
ing c-di-GMP because they miss residues involved in c-di-GMP
binding or coordination of essential divalent metals (Fig. 4B) (3,
53). For example, SCO5511 lacks the signature “EAL”motif, while
SCO1397 lacks the N-terminal residues of the EAL domain
(Fig. 4B). Of the remaining two proteins, SCO2817, designated
CdgA, was recently shown to function as a DGC (17). Therefore,
among the S. coelicolor EAL domain proteins, only RmdA and
SCO5495 may be enzymatically active (Fig. 4B). Below, we show
that SCO5495 is a c-di-GMP PDE involved in colonymorphology
and developmental control, and therefore we designated it RmdB.
We used SCO1397, predicted to be enzymatically incompetent in
the initial stages of experimental analysis, as a negative control.
RmdA and RmdB appear to be highly conserved among strep-
tomycetes.Orthologs of both proteins are encoded in the genomes
of Streptomyces avermitilis, S. venezuelae, S. hygroscopicus, S. gri-
seus, S. flavogriseus, S. bingchenggensis, S. violaceusniger, and S.
FIG 2 The rmdA and rmdB mutations delay S. coelicolor sporulation. Shown
are representative phase-contrast micrographs (1,000) of S. coelicolor aerial
hyphae viewed from impression slides after 3 and 7 days of growth at 30°C on
MS agar. The wild-type (WT) strain is characterized by aerial filaments that
have undergone division to produce evenly spaced, consistently sized spores
separated by complete septa at day 3. The spores begin to disperse by day 7. The
rmdA and rmdB mutants exhibit a delay in sporulation, producing primarily
undifferentiated aerial hyphae on day three andmany long spore chains by day
seven.
FIG 3 Transposon insertion sites. Genetic maps showing the rmdA (SCO0928)
and rmdB (SCO5495) regions. SCO0929 and rmdA form a potential operon.
The solid wedge represents the location of the Tn5 minitransposon insertion
through which TH1 (rmdA::Tn5) was originally isolated by in vivomutagene-
sis. The hollowwedges represent the location of the in vitroTn5062 transposon
insertions in rmdA, SCO0929, and rmdB (7).
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scabiei. They are also present in other filamentous actinomycetes.
Furthermore, the potential rmdA-SCO0929 operon is preserved in
streptomycetes and representatives of the suborder Frankineae,
e.g., Geodermatophilus obscurus and Nakamurella multipartita.
The high degree of conservation suggests that the regulatory
mechanism(s) through which RmdA and RmdB are involved in
colony morphology and development is likely conserved in fila-
mentous actinomycetes.
RmdA is a hemoprotein. We noticed that in addition to
RmdA, two S. coelicolor GGDEF and/or EAL domain proteins,
CdgA and SCO5511, contain PAS9 domains (Fig. 4A), which sug-
gests that they may bind a common ligand and respond to the
same primary signal. To investigate the nature of the putative
ligand bound to the PAS9 domain of RmdA, we reconstituted the
FIG 4 Analysis of S. coelicolor EAL domain proteins. (A) Protein domain architectures derived from the Pfam database (21). (B) Sequence alignment of themost
conserved regions of the EAL domains. #HMM, hiddenMarkovmodel-derived consensus sequence of the EAL domain. Residues involved in c-di-GMP binding
inferred from the X-ray structure of an EAL domain PDE are shown on a green background; residues involved in coordinating catalytic metals are shown on a
yellow background (3).
FIG 5 c-di-GMPPDE activity of RmdA andRmdB. (A) Increase in swimming
zones in semisolid agar of E. coli strain MG1655 yhjH with MBP-RmdA and
MBP-RmdB. Assays were run as described earlier (19). (B) Kinetics of c-di-
GMPhydrolysis byMBP-RmdA andMBP-RmdB. The PDE assays shown here
were performed in the PDE assay buffer containing 5 mM Mg2 and 5 mM
Mn2 (MBP-RmdA) or 5 mMMg2 (MBP-RmdB) (53).
FIG 6 Intracellular c-di-GMP levels in the S. coelicolor PDEmutants. The level
of c-di-GMP for the rmdA rmdBdoublemutantwas approximately three times
that of the wild type and single mutant strains. c-di-GMP was extracted as
described previously (8) from cells grown on cellulosemembranes onMS agar
for 70 h at 30°C and quantified by LC-MS/MS.
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MBP-RmdA (PAS9-GGGDEF-EAL) fusion with common PAS
domain ligands, FAD, FMN, and hemin (27).MBP-RmdAdid not
bind FADor FMN in vitro (not shown), but it did bind heminwith
a nearly equimolar stoichiometry (Fig. 7A). Further, upon close
inspection of the spectra of theMBP-RmdA protein purified from
the E. coli overexpression strain, we noticed that it already con-
tained traces of heme (Fig. 7A, inset).
To investigate the specificity of heme binding, we reduced the
protein-hemin complex with dithionite under anoxic conditions.
We observed a shift in the Soret band (from 412 nm to 424 nm)
and sharpening of the - and -peaks in the 500- to 600-nm
region of the spectrum. These changes are characteristic of the
formation of the reduced, Fe(II), deoxy form with hexacoordi-
nated heme iron, where two axial ligands are provided by amino
acids of the protein (Fig. 7B). Addition of CO, a gaseous ligand
that has high affinity to the majority of hemoproteins, resulted in
further sharpening of the Soret band (421.5 nm) and noticeable
changes in the - and -peaks of heme, suggestive of changes in
the heme binding pocket thatmost likely result fromCOreplacing
a distal (sixth) amino acid ligand of heme (Fig. 7B). Addition of
oxygen to the deoxy Fe(II) form also resulted in spectral changes,
albeit smaller in scope than those that originatedwith the addition
of CO (Fig. 7B). These results establish that RmdA binds heme
specifically and is capable of responding to gaseous ligands, which
in turn suggest that conformational changes in the heme-binding
pocket might affect the activity of RmdA.
We tested whether PDE activity of the holo-MBP-RmdA pro-
tein is affected byCOor oxygen, butwe observed no changes using
several independently purified protein preparations, nor did we
observe changes in PDE activity when the oxidized, Fe(III), met
form of the protein was compared to the reduced, Fe(II), deoxy
form or the apoprotein was compared to the holoprotein. At pres-
ent, we don’t understand why activity of RmdA appears to be
decoupled from the sensory input. Several possibilities exist (see
Discussion) and will be explored in the future.
To gain insight into the possibility that CdgA or SCO5511
binds heme, we compared the sequences of their PAS9 domains
with that of RmdA. We found these sequences to be highly diver-
gent and lacking conserved residues (e.g., His) that often ligate
heme iron. The highest similarity (30% identity) to the PAS9
domain of RmdA was displayed by the RmdA homologs from
Streptomyces species, as well as PAS9 proteins from cyanobacteria
and proteobacteria. Therefore, we could not predict whether
CdgA or SCO5511 binds heme. It appears that PAS domains have
evolved various ways to coordinate the heme ligand. For example,
the heme-PAS domains from oxygen-sensing c-di-GMP PDE, E.
coli DosP (16, 62), and histidine kinase Bradyrhizobium FixL (25,
29) have low,16% identity to PAS9 of RmdA.
RmdB (SCO5495) functions as a c-di-GMP PDE. To investi-
gate the involvement of SCO5495 in S. coelicolor development, we
constructed a Tn5062 mutant (Fig. 3B), designated TH101. We
observed that colonies of TH101 produced significantly less gray
spore pigment than the wild type (Fig. 1C and E). Microscopic
analysis revealed that after 3 days of growth, TH101 produced few
sporulated aerial filaments compared to the wild type (Fig. 2).
After 5 days, the number of spore chains increased, yet most of
them displayed a delay in the completion of septation. By day
seven, the quantity of spore chains was comparable to that ob-
served for the wild type at 3 days (Fig. 2). These phenotypes were
identical to the phenotypes of the rmdA mutants, TH1 and
TH100, thus suggesting that RmdB also modulates development
in S. coelicolor. The similarity between the rmdA and rmdB phe-
notypes suggested that RmdB functions as a c-di-GMP PDE.
The 746-aa RmdB protein contains an approximately 300-aa-
long N-terminal domain comprising seven transmembrane mo-
tifs followed by the GGDEF-EAL domain tandem (Fig. 4A). Nei-
ther the GGDEF nor EAL domains of SCO5495 contain readily
identifiable residues inconsistent with DGC or PDE activities, re-
spectively. To test for RmdB activity, we cloned its cytoplasmic
GGDEF-EAL module downstream of the MBP tag. The effects of
this fusion onmotility in the semisolid agar were assayed with the
E. coli test strains, MG1655 and MG1655 yhjH, and the effect of
MBP-RmdB was consistent with it acting as a PDE (Fig. 5A). The
MBP-SCO1397 fusion, used as a negative control, showed noPDE
activity (Fig. 5A), consistent with the sequence analysis presented
above.
We overexpressed and purified the cytoplasmic fragment of
A
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FIG 7 Characterization of RmdA as a heme-binding protein. (A) Electronic
absorbance spectra of the MBP-RmdA protein. Gray trace, as purified from E.
coli; black trace, after in vitro reconstitution with hemin. Inset, expanded ver-
sion of the spectrum showing a Soret band indicative of traces of heme present
in the protein purified from E. coli. (B) Reconstituted with heminMBP-RmdA
protein. Black solid trace, Fe(II), deoxy form; dotted trace, Fe(II), oxy form;
gray trace, Fe(II), carbonmonoxy form.
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RmdB and found that it has PDE activity in vitro. The relative
activity of the RmdB fragment was higher than that of RmdA (Fig.
5B), which is consistent with the motility-based assay (Fig. 5A). It
is noteworthy that activities of the truncated fusion proteins mea-
sured here are only approximations of the in vivo activities of
full-length proteins, which are further influenced by their respec-
tive sensory domains. The relative contributions of RmdA and
RmdB to regulation of development likely depend on environ-
mental conditions.
We measured the effect of the rmdBmutation on intracellular
c-di-GMP levels and found no significant differences between
TH101 and the wild type (Fig. 6). The lack of perturbations in
intracellular c-di-GMP levels is an indication that RmdB is specif-
ically involved in controlling S. coelicolor development.
RmdA and RmdB additively regulate colony morphology,
sporulation, and aerial mycelium development. To investigate
the relationship between RmdA and RmdB, we constructed the
rmdA rmdB doublemutant by inactivating the rmdB gene in strain
TH1. The colony morphology of the double mutant, TH106, was
strikingly different from those of the wild type and individual rmd
mutants in that the double mutant had abnormally large colonies
with the bald (bld) phenotype (Fig. 1D), i.e., it was completely
blocked in the development of aerial hyphae (Fig. 1E). The intro-
duction into the rmdA rmdB mutant of a cosmid containing the
wild-type rmdA or rmdB gene complemented the defect in aerial
mycelium formation (Fig. 1F).
We investigated the effect of the double mutant on intracellu-
lar c-di-GMP levels and found that these levels were increased by
approximately 3-fold compared to those for the wild type (Fig. 6).
Taken together, these data demonstrate that twoPDEs, RmdAand
RmdB, have at least partially overlapping functions in controlling
colony morphology, sporulation, and aerial mycelium develop-
ment in S. coelicolor.
DISCUSSION
S. coelicolor has been a model organism for studying cell division
and development in bacteria because mutants in the complex cy-
cle of morphological development can be readily identified both
visually and microscopically. Here we relied on decreased gray
pigmentation of Tn mutants as an indication of a potential defect
in sporulation to identify the rmdA gene. We showed that rmdA
encodes a c-di-GMP PDE. Another c-di-GMP PDE identified
here, RmdB, is also involved in developmental control and
morphological differentiation of S. coelicolor. According to our
bioinformatics analysis, RmdA and RmdB are the only EAL
domain-containing c-di-GMP PDEs present in S. coelicolor.
The membrane-localized SCO5218 containing an HD-GYP do-
main may potentially function as yet another c-di-GMP PDE in
this bacterium. Given the high degree of conservation among
RmdA and RmdB homologs, it is likely that c-di-GMP signaling
pathways modulate development in various filamentous actino-
mycetes. This notion emphasizes the need to understand c-di-
GMP signaling in this group of bacteria, which includes many
species that produce pharmacologically important antibiotics.
Numerous questions regarding the role of c-di-GMP in S. coe-
licolor remain. One set of questions concerns environmental and
intracellular signals that affect expression and activity of the en-
zymes involved in c-di-GMP signaling. In Streptomyces, develop-
ment is initiated by nutrient starvation and the production of
secondary metabolites like antibiotics (22). How these signals af-
fect c-di-GMP synthesis and degradation remains to be investi-
gated.
In this study, we noticed that RmdA is a hemoprotein and
therefore is expected to sense gaseous ligands or redox changes.
Interestingly, in several proteobacterial species, including Glu-
conacetobacter xylinus, E. coli, and Bordetella pertussis (12, 62, 63),
the oxygen concentration affects c-di-GMP synthesis or hydroly-
sis via heme-containing enzymes. However, studies of the role for
oxygen in Streptomyces development have been mainly confined
to antibiotic production in industrial cultures, not mechanistic
studies (2, 37, 64). While RmdA is capable of sensing gaseous
ligands, its PDE activity is surprisingly nonresponsive to pertur-
bations. The apparent disconnect between the sensory input and
output activity of RmdA may be due to various reasons. It is pos-
sible that proper experimental conditions were not found or that
the MBP-RmdA fusion was impaired due to the MBP tag or the
lack of the N-terminal domain X. It is also possible that RmdA
gains responsiveness only in a complex with its cognate DGC.
Several c-di-GMP PDEs have now been documented to function
in signaling complexes (48, 61). Yet another scenario is that RmdA
is a bifunctional GGDEF-EAL protein with a constitutive PDE
activity. An inactivation of the EAL domain (either by proteolysis
or by interactions with an RmdA partner) may be required to
unmask the DGC activity of the GGDEF domain, and the DGC
activitymay be designed to be regulated via a heme-PAS9 domain.
Examples of such unusual regulation in the bifunctional GGDEF-
EAL proteins are beginning to emerge (57, 60).
One potential interaction partner of RmdA could be SCO0929,
whose gene is located in an apparent operon with rmdA (Fig. 3),
and the operon is conserved among filamentous actinomycetes.
While in this study we did not observe visible developmental de-
fects of the SCO0929 mutant, additional experimental conditions
may be required to uncover its role. Signal sensing and processing
in SCO0929-RmdA and the PAS9 domain proteins CdgA and
SCO5511 also deserve further investigation.
A second set of questions concerns organization and specificity
of c-di-GMP signaling pathways in S. coelicolor. While the issue of
whether unique modules comprising DGCs and PDEs signal via
dedicated c-di-GMP receptors (effector proteins) to unique tar-
gets or whether all DGCs and PDEs contribute to a total intracel-
lular pool remains somewhat controversial, more and more evi-
dence points toward specific cascades as a prevalent regulatory
modality. A recent study where each DGC of the tiny bacterium
Bdellovibrio was shown to have a specific phenotype that did not
overlap with phenotypes controlled by other DGCs (28) provided
yet another convincing argument in support of target-specific c-
di-GMP signaling modules. We found that either the rmdA or
rmdB mutation could cause a pronounced developmental delay,
yet neither mutation resulted in significant perturbations in the
total intracellular c-di-GMP levels (Fig. 6). This is consistent with
the interpretation that a local, as opposed to a total, c-di-GMP
pool is important for developmental regulation in S. coelicolor. It
further shows a measure of specificity with which the RmdA and
RmdB PDEs jointly guard c-di-GMP-dependent targets involved
in development.
Recent experiments by the Buttner group showed that overex-
pression of S. coelicolor DGCs encoded by cdgA or cdgB (SCO4281)
block aerial mycelium formation (17, 59), i.e., produce the same
bald phenotype as does the rmdA rmdB double mutant. It is likely
that RmdA and RmdB counterbalance the effects of CdgA and
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CdgB. Whether CdgA, CdgB, RmdA, and RmdB are organized in
specific signaling modules and, if so, how these modules operate
remain to be investigated. It is peculiar that expression of cdgA and
cdgB is regulated by BldD, the transcription factor affecting mul-
tiple developmentally regulated genes. BldD binding sites are also
present upstream of SCO5511 (60), yet another predicted DGC
(unpublished data), but they are not present upstream of rmdA or
rmdB.
The third set of questions concerns molecular targets of c-di-
GMP that result in developmental and colony morphology phe-
notypes and mechanisms through which c-di-GMP exerts its ef-
fects. In order to erect upward into the air and to form aerial
hyphae, S. coelicolor filaments must break the surface tension cre-
ated by the aqueous environment of the vegetativemycelium.Two
overlapping mechanisms are involved in overcoming surface ten-
sion in S. coelicolor, i.e., chaplin proteins and the SapB protein (10,
15, 18, 31). We hypothesize that these may constitute c-di-GMP
targets. However, at present little is known about regulatory path-
ways affecting synthesis or activities of these proteins.
Another important question that cannot yet be answered con-
cerns identities of the S. coelicolor c-di-GMP receptors/effectors
that mediate the effects of c-di-GMP on ultimate targets. The
readily recognizable c-di-GMP receptors are represented by PilZ
domains (1, 50), I sites in the enzymatically inactive GGDEF do-
mains (11), or enzymatically inactive EAL domains (40). c-di-
GMP receptors that are not based on PilZ, EAL, or GGDEF do-
mains are difficult to recognize because their c-di-GMP-binding
patterns are not readily identifiable (38). The PilZ domains are not
encoded in the Streptomyces genomes. Among the GGDEF do-
main proteins, only CdgB and SCO5511 contain I sites (60), and
both function as a DGC (60; unpublished data). SCO1397 is the
only enzymatically inactive EAL domain protein that is not a
DGC. While we cannot completely exclude the possibility that it
binds c-di-GMP, this is unlikely. Overexpressed SCO1397 did not
improve motility of MG1655 yhjH in the semisolid agar (Fig. 5A),
in contrast to the case with other c-di-GMP receptors that serve as
c-di-GMP sinks anddecrease intracellular c-di-GMP levels (29). It
therefore appears that identification of c-di-GMP receptors in
streptomycetes will present a formidable challenge.
Finally, we would like to note that while the importance of the
c-di-GMP signaling pathways in lifestyle changes in the proteo-
bacteria has been well appreciated and the mechanisms of regula-
tion are being elucidated (27, 39, 46), the studies of c-di-GMP
signaling pathways in Gram-positive bacteria are still in their in-
fancy. Our study, along with those of Buttner and colleagues (17,
59), reveals an apparently conserved function of c-di-GMP signal-
ing inmodulation of development in actinomycetes. This extends
the realm of processes controlled by c-di-GMP and suggests that
future studies in the Gram-positive bacteria may result in new,
yet-unanticipated processes controlled by this second messenger,
new kinds of c-di-GMP receptors, and new regulatory mecha-
nisms.
ACKNOWLEDGMENTS
We are indebted to Paul Dyson for providing the Tn5062 mutagenized
cosmids used for strain construction and to A. Daniel Jones, Lijun Chen,
and Bev Chamberlin for c-di-GMP quantification via LC-MS.
Funding for this study was provided by the William J. von Liebig
Foundation (to J.A.B.), NSF grant MCB 1052575 (to M.G.), and a Sigma
Xi Grant-in-Aid of Research, administered by the National Academy of
Sciences (to R.C.J.). We are grateful to the von Liebig Foundation for
fellowships (to T.D.H. and N.T.K.), to the American Society for Microbi-
ology for Undergraduate Research Fellowships (to T.D.H., R.C.J., and
N.T.K.), and for Merck/AAAS Undergraduate Science Research Program
funding (to J.A.B. and R.M.G.).
REFERENCES
1. Amikam D, Galperin MY. 2006. PilZ domain is part of the bacterial
c-di-GMP binding protein. Bioinformatics 22:3–6.
2. Bankar SB, Singhal RS. 2011. Improved poly-epsilon-lysine biosynthesis
using Streptomyces noursei NRRL 5126 by controlling dissolved oxygen
during fermentation. J. Microbiol. Biotechnol. 21:652–658.
3. Barends TR, et al. 2009. Structure and mechanism of a bacterial light-
regulated cyclic nucleotide phosphodiesterase. Nature 459:1015–1018.
4. Bennett JA. 2007.Molecular genetic analysis of division and development
in Streptomyces coelicolor. Ph.D. dissertation. Duquesne University, Pitts-
burgh, PA.
5. Bennett JA, McCormick JR. 2001. Two new loci affecting cell division
identified as suppressors of an ftsQ-null mutation in Streptomyces coeli-
color A3(2). FEMS Microbiol. Lett. 202:251–256.
6. Bentley SD, et al. 2002. Complete genome sequence of the model actino-
mycete Streptomyces coelicolor A3(2). Nature 417:141–147.
7. Bishop A, Fielding S, Dyson P, Herron P. 2004. Systematic insertional
mutagenesis of a streptomycete genome: a link between osmoadaptation
and antibiotic production. Genome Res. 14:893–900.
8. Bobrov AG, et al. 2011. Systematic analysis of cyclic di-GMP signalling
enzymes and their role in biofilm formation and virulence in Yersinia
pestis. Mol. Microbiol. 79:533–551.
9. Bordeleau E, Fortier LC, Malouin F, Burrus V. 2011. c-di-GMP turn-
over in Clostridium difficile is controlled by a plethora of diguanylate cy-
clases and phosphodiesterases. PLoS Genet. 7:e1002039. doi:10.1371/
journal.pgen.1002039.
10. Capstick DS, Willey JM, Buttner MJ, Elliot MA. 2007. SapB and the
chaplins: connections between morphogenetic proteins in Streptomyces
coelicolor. Mol. Microbiol. 64:602–613.
11. Chan C, et al. 2004. Structural basis of activity and allosteric control of
diguanylate cyclase. Proc. Natl. Acad. Sci. U. S. A. 101:17084–17089.
12. Chang AL, et al. 2001. Phosphodiesterase A1, a regulator of cellulose
synthesis in Acetobacter xylinum, is a heme-based sensor. Biochemistry
40:3420–3426.
13. Chater KF. 2000. Developmental decisions during sporulation in the aer-
ial mycelium in Streptomyces, p 33–48. In Brun YV, Shimkets LJ (ed),
Prokaryotic development. ASM Press, Washington, DC.
14. Christen M, Christen B, Folcher M, Schauerte A, Jenal U. 2005. Iden-
tification and characterization of a cyclic di-GMP-specific phosphodies-
terase and its allosteric control by GTP. J. Biol. Chem. 280:30829–30837.
15. Claessen D, et al. 2003. A novel class of secreted hydrophobic proteins is
involved in aerial hyphae formation in Streptomyces coelicolor by forming
amyloid-like fibrils. Genes Dev. 17:1714–1726.
16. Delgado-Nixon VM, Gonzalez G, Gilles-Gonzalez MA. 2000. Dos, a
heme-binding PAS protein from Escherichia coli, is a direct oxygen sensor.
Biochemistry 39:2685–2691.
17. den Hengst CD, et al. 2010. Genes essential for morphological develop-
ment and antibiotic production in Streptomyces coelicolor are targets of
BldD during vegetative growth. Mol. Microbiol. 78:361–379.
18. Elliot MA, et al. 2003. The chaplins: a family of hydrophobic cell-surface
proteins involved in aerial mycelium formation in Streptomyces coelicolor.
Genes Dev. 17:1727–1740.
19. Fang X, Gomelsky M. 2010. A post-translational, c-di-GMP-dependent
mechanism regulating flagellar motility. Mol. Microbiol. 76:1295–1305.
20. Ferreira RB, Antunes LC, Greenberg EP, McCarter LL. 2008. Vibrio
parahaemolyticus ScrC modulates cyclic dimeric GMP regulation of gene
expression relevant to growth on surfaces. J. Bacteriol. 190:851–860.
21. Finn RD, et al. 2010. The Pfam protein families database. Nucleic Acids
Res. 38:D211–D222.
22. Flardh K, Buttner MJ. 2009. Streptomyces morphogenetics: dissecting
differentiation in a filamentous bacterium. Nat. Rev. Microbiol. 7:36–49.
23. Galperin MY, Natale DA, Aravind L, Koonin EV. 1999. A specialized
version of the HD hydrolase domain implicated in signal transduction. J.
Mol. Microbiol. Biotechnol. 1:303–305.
24. Gomelsky M, Kaplan S. 1998. AppA, a redox regulator of photosystem
Hull et al.
4650 jb.asm.org Journal of Bacteriology
 o
n
 O
ctober 6, 2015 by O
TTERBEIN UNIVERSITY
http://jb.asm.org/
D
ow
nloaded from
 
formation in Rhodobacter sphaeroides 2.4.1, is a flavoprotein. Identifica-
tion of a novel fad binding domain. J. Biol. Chem. 273:35319–35325.
25. Gong W, et al. 1998. Structure of a biological oxygen sensor: a new
mechanism for heme-driven signal transduction. Proc. Natl. Acad. Sci.
U. S. A. 95:15177–15182.
26. Hengge R. 2009. Principles of c-di-GMP signalling in bacteria. Nat. Rev.
Microbiol. 7:263–273.
27. Henry JT, Crosson S. 2011. Ligand-binding PAS domains in a genomic,
cellular, and structural context. Annu. Rev. Microbiol. 65:261–286.
28. Hobley L, et al. 2012. Discrete cyclic di-GMP-dependent control of bac-
terial predation versus axenic growth in Bdellovibrio bacteriovorus. PLoS
Pathog. 8:e1002493. doi:10.1371/journal.ppat.1002493.
29. Key J, Moffat K. 2005. Crystal structures of deoxy and CO-bound bj-
FixLH reveal details of ligand recognition and signaling. Biochemistry
44:4627–4635.
30. Kieser T, Bibb MJ, Buttner MJ, Chater KF, Hopwood DA. 2000.
Practical Streptomyces genetics. The John Innes Foundation, Colney,
United Kingdom.
31. Kodani S, et al. 2004. The SapB morphogen is a lantibiotic-like peptide
derived from the product of the developmental gene ramS in Streptomyces
coelicolor. Proc. Natl. Acad. Sci. U. S. A. 101:11448–11453.
32. Kumar M, Chatterji D. 2008. Cyclic di-GMP: a second messenger re-
quired for long-term survival, but not for biofilm formation, inMycobac-
terium smegmatis. Microbiology 154:2942–2955.
33. Letunic I, Doerks T, Bork P. 2012. SMART 7: recent updates to the
protein domain annotation resource. Nucleic Acids Res. 40:D302–D305.
34. Lovering AL, Capeness MJ, Lambert C, Hobley L, Sockett RE. 2011. The
structure of an unconventionalHD-GYPprotein fromBdellovibrio reveals
the roles of conserved residues in this class of cyclic-di-GMP phosphodi-
esterases. mBio 2(5):e00163-11. doi:10.1128/mBio. 00163-11.
35. MacNeil DJ. 1988. Characterization of a unique methyl-specific restric-
tion system in Streptomyces avermitilis. J. Bacteriol. 170:5607–5612.
36. McCormick JR, Losick R. 1996. Cell division gene ftsQ is required for
efficient sporulation but not growth and viability in Streptomyces coelicolor
A3(2). J. Bacteriol. 178:5295–5301.
37. Mehmood N, et al. 2011. Oxygen supply controls the onset of pristina-
mycins production by Streptomyces pristinaespiralis in shaking flasks. Bio-
technol. Bioeng. 108:2151–2161.
38. Mills E, Pultz IS, Kulasekara HD, Miller SI. 2011. The bacterial second
messenger c-di-GMP: mechanisms of signalling. Cell. Microbiol. 13:
1122–1129.
39. Moskvin OV, Kaplan S, Gilles-Gonzalez MA, Gomelsky M. 2007. Novel
heme-based oxygen sensor with a revealing evolutionary history. J. Biol.
Chem. 282:28740–28748.
40. Newell PD, Monds RD, O’Toole GA. 2009. LapD is a bis-(3=,5=)-cyclic
dimeric GMP-binding protein that regulates surface attachment by Pseu-
domonas fluorescens Pf0-1. Proc. Natl. Acad. Sci. U. S. A. 106:3461–3466.
41. Oh SH, Chater KF. 1997. Denaturation of circular or linear DNA facili-
tates targeted integrative transformation of Streptomyces coelicolor A3(2):
possible relevance to other organisms. J. Bacteriol. 179:122–127.
42. Paget MS, Chamberlin L, Atrih A, Foster SJ, Buttner MJ. 1999. Evidence
that the extracytoplasmic function sigma factor sigmaE is required for
normal cell wall structure in Streptomyces coelicolor A3(2). J. Bacteriol.
181:204–211.
43. Paul R, et al. 2004. Cell cycle-dependent dynamic localization of a bac-
terial response regulator with a novel di-guanylate cyclase output domain.
Genes Dev. 18:715–727.
44. RedenbachM, et al. 1996. A set of ordered cosmids and a detailed genetic
and physicalmap for the 8Mb Streptomyces coelicolorA3(2) chromosome.
Mol. Microbiol. 21:77–96.
45. Romling U, Simm R. 2009. Prevailing concepts of c-di-GMP signaling.
Contrib. Microbiol. 16:161–181.
46. Ross P, et al. 1990. The cyclic diguanylic acid regulatory system of cellu-
lose synthesis in Acetobacter xylinum. Chemical synthesis and biological
activity of cyclic nucleotide dimer, trimer, and phosphothioate deriva-
tives. J. Biol. Chem. 265:18933–18943.
47. Ross P, et al. 1987. Regulation of cellulose synthesis in Acetobacter xyli-
num by cyclic diguanylic acid. Nature 325:279–281.
48. Ryan RP, Dow JM. 2010. Intermolecular interactions between HD-GYP
and GGDEF domain proteins mediate virulence-related signal transduc-
tion in Xanthomonas campestris. Virulence 1:404–408.
49. Ryan RP, et al. 2006. Cell-cell signaling in Xanthomonas campestris in-
volves an HD-GYP domain protein that functions in cyclic di-GMP turn-
over. Proc. Natl. Acad. Sci. U. S. A. 103:6712–6717.
50. Ryjenkov DA, Simm R, Romling U, Gomelsky M. 2006. The PilZ
domain is a receptor for the secondmessenger c-di-GMP: the PilZ domain
protein YcgR controls motility in enterobacteria. J. Biol. Chem. 281:
30310–30314.
51. Ryjenkov DA, Tarutina M, Moskvin OV, Gomelsky M. 2005. Cyclic
diguanylate is a ubiquitous signaling molecule in bacteria: insights into
biochemistry of the GGDEF protein domain. J. Bacteriol. 187:1792–1798.
52. Schirmer T, Jenal U. 2009. Structural and mechanistic determinants of
c-di-GMP signalling. Nat. Rev. Microbiol. 7:724–735.
53. Schmidt AJ, Ryjenkov DA, Gomelsky M. 2005. The ubiquitous protein
domain EAL is a cyclic diguanylate-specific phosphodiesterase: enzymat-
ically active and inactive EAL domains. J. Bacteriol. 187:4774–4781.
54. Tal R, et al. 1998. Three cdg operons control cellular turnover of cyclic
di-GMP in Acetobacter xylinum: genetic organization and occurrence of
conserved domains in isoenzymes. J. Bacteriol. 180:4416–4425.
55. Tamayo R, Pratt JT, Camilli A. 2007. Roles of cyclic diguanylate in the
regulation of bacterial pathogenesis. Annu. Rev. Microbiol. 61:131–148.
56. Tamayo R, Tischler AD, Camilli A. 2005. The EAL domain protein VieA
is a cyclic diguanylate phosphodiesterase. J. Biol. Chem. 280:33324–
33330.
57. Tarutina M, Ryjenkov DA, Gomelsky M. 2006. An unorthodox bacte-
riophytochrome fromRhodobacter sphaeroides involved in turnover of the
second messenger c-di-GMP. J. Biol. Chem. 281:34751–34758.
58. Taylor BL, Zhulin IB. 1999. PAS domains: internal sensors of oxygen,
redox potential, and light. Microbiol. Mol. Biol. Rev. 63:479–506.
59. Tran NT, Den Hengst CD, Gomez-Escribano JP, Buttner MJ. 2011.
Identification and characterization of CdgB, a diguanylate cyclase in-
volved in developmental processes in Streptomyces coelicolor. J. Bacteriol.
193:3100–3108.
60. Trimble MJ, McCarter LL. 2011. Bis-(3=-5=)-cyclic dimeric GMP-linked
quorum sensing controls swarming in Vibrio parahaemolyticus. Proc.
Natl. Acad. Sci. U. S. A. 108:18079–18084.
61. Tuckerman JR, Gonzalez G, Gilles-Gonzalez MA. 2011. Cyclic di-GMP
activation of polynucleotide phosphorylase signal-dependent RNA pro-
cessing. J. Mol. Biol. 407:633–639.
62. Tuckerman JR, et al. 2009. An oxygen-sensing diguanylate cyclase and
phosphodiesterase couple for c-di-GMP control. Biochemistry 48:9764–
9774.
63. Wan X, et al. 2009. Globins synthesize the second messenger bis-(3=-5=)-
cyclic diguanosine monophosphate in bacteria. J. Mol. Biol. 388:262–270.
64. Wei ZH, Bai L, Deng Z, Zhong JJ. 2011. Enhanced production of
validamycin A by H2O2-induced reactive oxygen species in fermentation
of Streptomyces hygroscopicus 5008. Bioresour. Technol. 102:1783–1787.
65. Wolf A, Visick K (ed). 2010. The secondmessenger cyclic di-GMP, p 356.
ASM Press, Washington, DC.
c-Di-GMP Phosphodiesterases in Streptomyces Development
September 2012 Volume 194 Number 17 jb.asm.org 4651
 o
n
 O
ctober 6, 2015 by O
TTERBEIN UNIVERSITY
http://jb.asm.org/
D
ow
nloaded from
 
